Log In
Print
BCIQ
Print
Print this Print this
 

AMG 745

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionMyostatin inhibitor
Molecular Target Myostatin (GDF8) (MSTN)
Mechanism of ActionMyostatin (GDF-8) inhibitor
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular atrophy
Indication DetailsTreat muscle loss due to disease; Treat muscle-wasting disorders
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today